DoW Bone Marrow Failure, Investigator-Initiated Research Award

Funding Opportunity Number: HT942526BMFRPIIRA

About the Opportunity

Supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in bone marrow failure (BMF) research and/or patient care. This Investigator-Initiated Research Award (IIRA) may involve translational and clinical research, including:

• Studies in preclinical models, research with human data and/or anatomical substances, and research with human subjects
• Correlative studies associated with a clinical trial(s) (however, this award mechanism does not support clinical trials)
• Investigational New Drug (IND)-enabling efforts such as lead compound characterization, formulation and stability assessments, absorption, distribution, metabolism and excretion, dose/response, and toxicology

Distinctive Features

• Allows for a partnering Principal Investigator (PI). Only the initiating PI submits a pre-application, but both PIs must submit full applications. The partnering PI’s application is an abbreviated package specific to their portion of the research project.
• All associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
• Requires preliminary data relevant to the proposed project.
• Supports clinical research studies but does not allow clinical trials.

Eligibility

Open to any type of entity, unrestricted.

Funding Details

• Estimated Total Program Funding: $1,250,000
• Expected Number of Awards: 1
• No cost sharing or matching requirement.

Key Dates

• Posted Date: June 17, 2026
• Last Updated Date: June 23, 2026
• Closing Date for Applications: November 4, 2026
• Archive Date: December 4, 2026

Contact Information

For assistance, contact the eBRAP Help Desk:

• Phone: 301-682-5507
• Email: help@eBRAP.org